John B Gordon1, Lori B Daniels2, Andrew M Kahn2, Susan Jimenez-Fernandez3, Matthew Vejar3, Fujito Numano3, Jane C Burns3. 1. San Diego Cardiac Center and Sharp Memorial Hospital, San Diego, California. Electronic address: jgordon552@mac.com. 2. Department of Medicine, University of California, San Diego, School of Medicine, La Jolla, California. 3. Department of Pediatrics, Rady Children's Hospital San Diego and the University of California, San Diego, School of Medicine, La Jolla, California.
Abstract
OBJECTIVES: The aim of this study was to characterize the range of management issues raised by adults with cardiovascular sequelae from Kawasaki disease (KD) in childhood. BACKGROUND: Aneurysms resulting from vascular inflammation associated with KD in childhood may remain clinically silent until adulthood. Adults with large aneurysms, unstable angina, or myocardial infarction following KD in childhood present unique challenges to interventional cardiologists and cardiothoracic surgeons. METHODS: In an observational study of adults with histories of KD in childhood, data were collected regarding the medical histories and outcomes of 154 adult KD patients, of whom 21 underwent either percutaneous interventions or surgery. RESULTS: Of the 21 subjects with interventions, 11 had been diagnosed with KD in childhood, and 10 had histories of KD-compatible illnesses. Seventeen subjects were asymptomatic until experiencing acute cardiovascular symptoms: acute myocardial infarction (n = 12), angina (n = 2), end-stage congestive heart failure requiring cardiac transplantation (n = 1), and claudication (n = 2). CONCLUSIONS: Cardiovascular complications in these subjects illustrate the following points: 1) even small to moderate-sized aneurysms that "normalize" on echocardiography in childhood can lead to stenosis and thrombosis decades after the acute illness; 2) coronary interventions without intravascular ultrasound may result in clinically significant underestimation of vessel luminal diameter; 3) failure to assess the extent of calcification may lead to suboptimal procedural outcomes; and 4) patients with symptomatic peripheral aneurysms may benefit from endarterectomy or resection. Interventional cardiologists should be aware of the potential challenges in treating this growing population of adults.
OBJECTIVES: The aim of this study was to characterize the range of management issues raised by adults with cardiovascular sequelae from Kawasaki disease (KD) in childhood. BACKGROUND:Aneurysms resulting from vascular inflammation associated with KD in childhood may remain clinically silent until adulthood. Adults with large aneurysms, unstable angina, or myocardial infarction following KD in childhood present unique challenges to interventional cardiologists and cardiothoracic surgeons. METHODS: In an observational study of adults with histories of KD in childhood, data were collected regarding the medical histories and outcomes of 154 adult KDpatients, of whom 21 underwent either percutaneous interventions or surgery. RESULTS: Of the 21 subjects with interventions, 11 had been diagnosed with KD in childhood, and 10 had histories of KD-compatible illnesses. Seventeen subjects were asymptomatic until experiencing acute cardiovascular symptoms: acute myocardial infarction (n = 12), angina (n = 2), end-stage congestive heart failure requiring cardiac transplantation (n = 1), and claudication (n = 2). CONCLUSIONS:Cardiovascular complications in these subjects illustrate the following points: 1) even small to moderate-sized aneurysms that "normalize" on echocardiography in childhood can lead to stenosis and thrombosis decades after the acute illness; 2) coronary interventions without intravascular ultrasound may result in clinically significant underestimation of vessel luminal diameter; 3) failure to assess the extent of calcification may lead to suboptimal procedural outcomes; and 4) patients with symptomatic peripheral aneurysms may benefit from endarterectomy or resection. Interventional cardiologists should be aware of the potential challenges in treating this growing population of adults.
Authors: Andrew M Kahn; Matthew J Budoff; Lori B Daniels; Jun Oyamada; John B Gordon; Jane C Burns Journal: Am J Cardiol Date: 2017-01-06 Impact factor: 2.778
Authors: Harry H Matundan; Jon Sin; Magali Noval Rivas; Michael C Fishbein; Thomas J Lehman; Shuang Chen; Roberta A Gottlieb; Timothy R Crother; Masanori Abe; Moshe Arditi Journal: JCI Insight Date: 2019-02-07
Authors: Yanfang P Zhu; Isaac Shamie; Jamie C Lee; Cameron J Nowell; Weiqi Peng; Shiela Angulo; Linh Nn Le; Yushan Liu; Huilai Miao; Hainan Xiong; Cathleen J Pena; Elizabeth Moreno; Eric Griffis; Stephanie G Labou; Alessandra Franco; Lori Broderick; Hal M Hoffman; Chisato Shimizu; Nathan E Lewis; John T Kanegaye; Adriana H Tremoulet; Jane C Burns; Ben A Croker Journal: J Clin Invest Date: 2021-10-15 Impact factor: 14.808
Authors: M Abe; D D Rastelli; A C Gomez; E Cingolani; Y Lee; P R Soni; M C Fishbein; T J A Lehman; K Shimada; T R Crother; S Chen; M Noval Rivas; M Arditi Journal: Clin Exp Immunol Date: 2019-12-09 Impact factor: 4.330
Authors: Jihoon Kim; Chisato Shimizu; Stephen F Kingsmore; Narayanan Veeraraghavan; Eric Levy; Andre M Ribeiro Dos Santos; Hai Yang; Jay Flatley; Long Truong Hoang; Martin L Hibberd; Adriana H Tremoulet; Olivier Harismendy; Lucila Ohno-Machado; Jane C Burns Journal: PLoS One Date: 2017-02-02 Impact factor: 3.240
Authors: Galina Lyskina; Olga Bockeria; Olga Shirinsky; Alena Torbyak; Anna Leontieva; Nina Gagarina; Anna Satyukova; Julia Kostina; Olga Vinogradova Journal: Glob Cardiol Sci Pract Date: 2017-10-31
Authors: S M Dietz; D van Stijn; D Burgner; M Levin; I M Kuipers; B A Hutten; T W Kuijpers Journal: Eur J Pediatr Date: 2017-06-27 Impact factor: 3.183